{"title":"在同一患者中,有无术前清除准备的小肠视频胶囊内窥镜的可见性和性能。","authors":"Margalit Yehuda Reuma, Davidov Yana, Selinger Limor, Ungar Bella, Lahat Adi, Yablecovitch Doron, Neuman Sandra, Kopylov Uri, Ben Horin Shomron, Eliakim Rami","doi":"10.1111/jgh.16954","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Small bowel (SB) video capsule endoscopy (VCE) is an established diagnostic tool for the investigation of SB pathologies. Despite clinical studies and a few meta-analyses, an area of continuing controversy is the role of pre-procedural bowel preparation.</p><p><strong>Objectives: </strong>We compared the visibility and performance of VCE with and without purge preparation in the same patients.</p><p><strong>Design: </strong>Post hoc analysis of randomized control trial.</p><p><strong>Methods: </strong>This is a post hoc analysis of the prospective randomized CURE-CD Trial (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease trial). Established Crohn's disease (CD) patients in clinical remission were enrolled and classified into two groups according to relapse risk assessment. All patients are followed up in our clinic and undergo laboratory tests every 3 months and serial VCE studies every 6 months. The first VCE is done after bowel preparation with a clear liquid diet, PEG, and laxative, whereas the subsequent VCEs, when disease is confined to SB only, are done after a day on clear liquid diet. The VCE visibility is rated (1-4 points) by a blind observer, unaware to the preparation regimen.</p><p><strong>Results: </strong>Forty patients who underwent at least two VCEs, at baseline and after 6 months were included. Visibility scores were similar in these two time points (3.15 vs. 3.10, p = 0.8). Among the low-risk patients' group (n = 16) in whom the clinical parameters (CDAI, CRP, and fecal calprotectin) have not changed significantly during this period, Inflammatory scores assessed by the capsule Lewis score (LS) and PillCam-CD score (PCDS) were similar (median LS 225 vs. 225, p = 0.87, median PCDS 4 vs. 2, p = 0.37).</p><p><strong>Conclusion: </strong>The visibility and performance of SB VCE for monitoring Crohn's disease is not significantly influenced by purge preparation.</p><p><strong>Trial registration: </strong>Clinicatrials.gov identifier: NCT03555058.</p>","PeriodicalId":15877,"journal":{"name":"Journal of Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Visibility and Performance of Small Bowel Video Capsule Endoscopy With and Without Pre-Procedural Purge Preparation in the Same Patients.\",\"authors\":\"Margalit Yehuda Reuma, Davidov Yana, Selinger Limor, Ungar Bella, Lahat Adi, Yablecovitch Doron, Neuman Sandra, Kopylov Uri, Ben Horin Shomron, Eliakim Rami\",\"doi\":\"10.1111/jgh.16954\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Small bowel (SB) video capsule endoscopy (VCE) is an established diagnostic tool for the investigation of SB pathologies. Despite clinical studies and a few meta-analyses, an area of continuing controversy is the role of pre-procedural bowel preparation.</p><p><strong>Objectives: </strong>We compared the visibility and performance of VCE with and without purge preparation in the same patients.</p><p><strong>Design: </strong>Post hoc analysis of randomized control trial.</p><p><strong>Methods: </strong>This is a post hoc analysis of the prospective randomized CURE-CD Trial (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease trial). Established Crohn's disease (CD) patients in clinical remission were enrolled and classified into two groups according to relapse risk assessment. All patients are followed up in our clinic and undergo laboratory tests every 3 months and serial VCE studies every 6 months. The first VCE is done after bowel preparation with a clear liquid diet, PEG, and laxative, whereas the subsequent VCEs, when disease is confined to SB only, are done after a day on clear liquid diet. The VCE visibility is rated (1-4 points) by a blind observer, unaware to the preparation regimen.</p><p><strong>Results: </strong>Forty patients who underwent at least two VCEs, at baseline and after 6 months were included. Visibility scores were similar in these two time points (3.15 vs. 3.10, p = 0.8). Among the low-risk patients' group (n = 16) in whom the clinical parameters (CDAI, CRP, and fecal calprotectin) have not changed significantly during this period, Inflammatory scores assessed by the capsule Lewis score (LS) and PillCam-CD score (PCDS) were similar (median LS 225 vs. 225, p = 0.87, median PCDS 4 vs. 2, p = 0.37).</p><p><strong>Conclusion: </strong>The visibility and performance of SB VCE for monitoring Crohn's disease is not significantly influenced by purge preparation.</p><p><strong>Trial registration: </strong>Clinicatrials.gov identifier: NCT03555058.</p>\",\"PeriodicalId\":15877,\"journal\":{\"name\":\"Journal of Gastroenterology and Hepatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Gastroenterology and Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/jgh.16954\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jgh.16954","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:小肠(SB)视频胶囊内窥镜(VCE)是一种成熟的小肠病理诊断工具。尽管有临床研究和一些荟萃分析,一个持续争议的领域是术前肠道准备的作用。目的:我们比较了在相同的患者中,有和没有清除制剂的VCE的可见性和性能。设计:随机对照试验的事后分析。方法:这是一项前瞻性随机CURE-CD试验(综合个体化主动治疗克罗恩病试验)的事后分析。纳入临床缓解的克罗恩病(CD)患者,根据复发风险评估分为两组。所有患者均在我院门诊随访,每3个月进行一次实验室检查,每6个月进行一次VCE系列研究。第一次VCE在肠道准备后用透明液体饮食、聚乙二醇和泻药进行,而随后的VCE,当疾病仅限于SB时,在透明液体饮食一天后进行。VCE的可见度由一个不知道准备方案的盲人观察者评定(1-4分)。结果:40例患者在基线和6个月后至少接受了两次vce。可见性评分在两个时间点相似(3.15 vs. 3.10, p = 0.8)。在低危患者组(n = 16)中,临床参数(CDAI、CRP和粪便钙保护蛋白)在此期间没有显著变化,胶囊Lewis评分(LS)和PillCam-CD评分(PCDS)评估的炎症评分相似(LS中位数225比225,p = 0.87, PCDS中位数4比2,p = 0.37)。结论:清除制剂对SB VCE监测克罗恩病的可视性和性能无显著影响。试验注册:clinicaterals .gov标识符:NCT03555058。
The Visibility and Performance of Small Bowel Video Capsule Endoscopy With and Without Pre-Procedural Purge Preparation in the Same Patients.
Background: Small bowel (SB) video capsule endoscopy (VCE) is an established diagnostic tool for the investigation of SB pathologies. Despite clinical studies and a few meta-analyses, an area of continuing controversy is the role of pre-procedural bowel preparation.
Objectives: We compared the visibility and performance of VCE with and without purge preparation in the same patients.
Design: Post hoc analysis of randomized control trial.
Methods: This is a post hoc analysis of the prospective randomized CURE-CD Trial (Comprehensive individUalized pRoactive ThErapy of Crohn's Disease trial). Established Crohn's disease (CD) patients in clinical remission were enrolled and classified into two groups according to relapse risk assessment. All patients are followed up in our clinic and undergo laboratory tests every 3 months and serial VCE studies every 6 months. The first VCE is done after bowel preparation with a clear liquid diet, PEG, and laxative, whereas the subsequent VCEs, when disease is confined to SB only, are done after a day on clear liquid diet. The VCE visibility is rated (1-4 points) by a blind observer, unaware to the preparation regimen.
Results: Forty patients who underwent at least two VCEs, at baseline and after 6 months were included. Visibility scores were similar in these two time points (3.15 vs. 3.10, p = 0.8). Among the low-risk patients' group (n = 16) in whom the clinical parameters (CDAI, CRP, and fecal calprotectin) have not changed significantly during this period, Inflammatory scores assessed by the capsule Lewis score (LS) and PillCam-CD score (PCDS) were similar (median LS 225 vs. 225, p = 0.87, median PCDS 4 vs. 2, p = 0.37).
Conclusion: The visibility and performance of SB VCE for monitoring Crohn's disease is not significantly influenced by purge preparation.
期刊介绍:
Journal of Gastroenterology and Hepatology is produced 12 times per year and publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatology, gastroenterology and endoscopy. Papers cover the medical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas. All submitted papers are reviewed by at least two referees expert in the field of the submitted paper.